194 related articles for article (PubMed ID: 1683024)
1. Recent advances in the clinical pharmacology of Parkinson's disease.
Montastruc JL
Therapie; 1991; 46(4):293-303. PubMed ID: 1683024
[TBL] [Abstract][Full Text] [Related]
2. [Antiparkinsonian drugs].
Rascol A; Montastruc JL; Rascol O
Rev Prat; 1989 Mar; 39(8):663-9. PubMed ID: 2567051
[TBL] [Abstract][Full Text] [Related]
3. Update on the management of Parkinson's disease.
Standaert DG; Stern MB
Med Clin North Am; 1993 Jan; 77(1):169-83. PubMed ID: 8093493
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Parkinson's disease.
Lieberman A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in pharmacological therapy of Parkinson's disease.
Riederer P; Lange KW; Youdim MB
Adv Neurol; 1993; 60():626-35. PubMed ID: 8093582
[TBL] [Abstract][Full Text] [Related]
6. A rationale for dopamine agonists as primary therapy for Parkinson's disease.
Olanow CW
Can J Neurol Sci; 1992 Feb; 19(1 Suppl):108-12. PubMed ID: 1349262
[TBL] [Abstract][Full Text] [Related]
7. [Current therapeutic approach in Parkinson disease].
Przedborski S; Levivier M
Rev Med Brux; 1992 Dec; 13(10):360-6. PubMed ID: 1480887
[TBL] [Abstract][Full Text] [Related]
8. Apomorphine in patients with Parkinson's disease.
Muguet D; Broussolle E; Chazot G
Biomed Pharmacother; 1995; 49(4):197-209. PubMed ID: 7669939
[TBL] [Abstract][Full Text] [Related]
9. New concepts in the treatment of Parkinson's disease.
Ahlskog JE; Wilkinson JM
Am Fam Physician; 1990 Feb; 41(2):574-84. PubMed ID: 1967895
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic agonists in the treatment of Parkinson's disease.
Goetz CG; Diederich NJ
Neurol Clin; 1992 May; 10(2):527-40. PubMed ID: 1350052
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
Henchcliffe C; Schumacher HC; Burgut FT
Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease.
Wolters EC; Calne DB
CMAJ; 1989 Mar; 140(5):507-14. PubMed ID: 2563667
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Agid Y; Barroche G; Bonnet AM; Javoy-Agid F; Kato G; Lhermitte F; Pollak P; Signoret JL
Biomedicine; 1979 Jun; 30(2):67-71. PubMed ID: 383169
[TBL] [Abstract][Full Text] [Related]
14. The place of the dopaminergic agonists in the treatment of Parkinson's disease: the view from the trenches.
King DB
Can J Neurol Sci; 1992 Feb; 19(1 Suppl):156-9. PubMed ID: 1349264
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for early Parkinson's disease.
Stacy M; Brownlee HJ
Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
[TBL] [Abstract][Full Text] [Related]
16. Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline.
Lieberman A
Neurology; 1992 Apr; 42(4 Suppl 4):37-40; discussion 41-8. PubMed ID: 1350073
[TBL] [Abstract][Full Text] [Related]
17. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
18. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
19. Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?
Montastruc JL; Rascol O; Senard JM; Houin G; Rascol A
J Neural Transm Suppl; 1995; 45():157-61. PubMed ID: 8748621
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Parkinson's disease. From theory to practice.
Ahlskog JE
Postgrad Med; 1994 Apr; 95(5):52-4, 57-8, 61-4 passim. PubMed ID: 8153048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
